Robeco Institutional Asset Management B.V. lifted its stake in UnitedHealth Group Inc (NYSE:UNH) by 12.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 499,194 shares of the healthcare conglomerate’s stock after acquiring an additional 55,304 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.05% of UnitedHealth Group worth $132,805,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. White Lighthouse Investment Management Inc. acquired a new position in UnitedHealth Group during the second quarter worth $324,000. Wells Fargo & Company MN increased its position in UnitedHealth Group by 0.5% during the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after buying an additional 39,480 shares during the last quarter. Sawtooth Solutions LLC increased its position in UnitedHealth Group by 34.4% during the third quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock worth $1,174,000 after buying an additional 1,129 shares during the last quarter. Page Arthur B acquired a new position in UnitedHealth Group during the third quarter worth $1,026,000. Finally, Granite Investment Advisors LLC increased its position in UnitedHealth Group by 1.4% during the second quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock worth $8,397,000 after buying an additional 476 shares during the last quarter. 85.43% of the stock is currently owned by institutional investors and hedge funds.
UNH stock opened at $276.55 on Friday. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.75. UnitedHealth Group Inc has a 52-week low of $208.48 and a 52-week high of $278.00. The stock has a market cap of $264.32 billion, a price-to-earnings ratio of 22.55, a PEG ratio of 1.58 and a beta of 0.78.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. During the same period in the prior year, the company earned $2.66 earnings per share. The business’s quarterly revenue was up 12.4% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Inc will post 12.81 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 1.30%. UnitedHealth Group’s payout ratio is presently 35.75%.
In related news, EVP D Ellen Wilson sold 15,393 shares of the stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the sale, the executive vice president now owns 66,402 shares in the company, valued at $17,549,384.58. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Steven H. Nelson sold 8,142 shares of the stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the completion of the sale, the chief executive officer now owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The disclosure for this sale can be found here. In the last quarter, insiders sold 69,568 shares of company stock valued at $18,539,877. 0.87% of the stock is owned by corporate insiders.
Several research firms have commented on UNH. BMO Capital Markets increased their target price on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, October 18th. Oppenheimer increased their target price on shares of UnitedHealth Group from $276.00 to $295.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 17th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price on the stock in a research report on Sunday, July 15th. Piper Jaffray Companies increased their target price on shares of UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 17th. Finally, Royal Bank of Canada increased their target price on shares of UnitedHealth Group from $282.00 to $284.00 and gave the stock a “$255.42” rating in a research report on Wednesday, July 18th. One investment analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $289.41.
ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Inc (UNH) Holdings Increased by Robeco Institutional Asset Management B.V.” was first published by American Banking News and is owned by of American Banking News. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.americanbankingnews.com/2018/11/10/unitedhealth-group-inc-unh-holdings-increased-by-robeco-institutional-asset-management-b-v.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Asset Allocation Models, Which is Right For You?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.